Skip to main content
Expanded access

Committed to developing safe and effective therapies for patients of all ages.

Tovorafenib is no longer available for expanded access or compassionate use in the United States (U.S.).

For medical inquiries in the U.S., please email [email protected].

Outside of the US, Day One has partnered with Ipsen. For any access/medical inquiries please email [email protected].